ON DEMAND MANUFACTURING STRATEGY TO DELIVER MULTIPLE DOSES OF FRESHLY CULTURED UMBILICAL CORD DERIVED MSCS IN THE CELLULAR IMMUNO-THERAPY FOR COVID-19 RELATED ARDS CLINICAL TRIAL

Khan, S.; English, S.; Hodgins, S.; Lalu, M.; Watpool, I.; Champagne, J.; Freund, D.; Möbius, M. Alexander; Rüdiger, M.; Fergusson, D.; Thébaud, B.; Stewart, D. J.; Courtman, D. W.

Khan, S.; English, S.; Hodgins, S.; Lalu, M.; Watpool, I.; Champagne, J.; Freund, D.; Möbius, M. Alexander; Rüdiger, M.; Fergusson, D.; Thébaud, B.; Stewart, D. J.; Courtman, D. W..

Cytotherapy (Elsevier Inc.) ; 25(6):S65-S65, 2023.

Article in English | Academic Search Complete | ID: covidwho-2324062

Keywords

MANUFACTURING cells; STROMAL cells; CLINICAL trials; ADULT respiratory distress syndrome; COVID-19; UMBILICAL cord

Fulltext

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: Academic Search Complete Type of study: Prognostic study / Randomized controlled trials Language: English Journal: Cytotherapy (Elsevier Inc.) Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google